Cargando…
Case Report: Resolution of remitting seronegative symmetrical synovitis with pitting edema during nivolumab therapy for gastric cancer
The anti-programmed cell death-1 (PD-1) antibody nivolumab has been shown to significantly prolong the survival of patients with unresectable advanced or recurrent gastric cancer (AGC). However, immune-related adverse events (irAEs), which show different profiles from those of cytotoxic agents or co...
Autores principales: | Ohmura, Hirofumi, Kondo, Moe, Uenomachi, Masato, Ariyama, Hiroshi, Ito, Mamoru, Tsuchihashi, Kenji, Ayano, Masahiro, Niiro, Hiroaki, Akashi, Koichi, Baba, Eishi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586790/ https://www.ncbi.nlm.nih.gov/pubmed/37869081 http://dx.doi.org/10.3389/fonc.2023.1260818 |
Ejemplares similares
-
Remitting seronegative symmetrical synovitis with pitting edema syndrome in maintenance hemodialysis
por: Matsugasumi, Toru, et al.
Publicado: (2020) -
Remitting seronegative symmetrical synovitis with pitting edema: a case report
por: Tanaka, Yasushi, et al.
Publicado: (2022) -
Nivolumab induced remitting seronegative symmetrical synovitis with pitting edema in a patient with melanoma: a case report
por: Ngo, Linh, et al.
Publicado: (2018) -
Syndrome of remitting seronegative symmetrical synovitis with pitting edema: A case series
por: Varshney, AN, et al.
Publicado: (2015) -
Remitting symmetrical seronegative synovitis and pitting edema syndrome with concomitant adenocarcinoma of the lung
por: Karahan, S
Publicado: (2019)